ARRAY BIOPHARMA (NASDAQ:ARRY)
2.03
+0.04 (2.01%)
| ARRAY BIOPHARMA (NASDAQ:ARRY) Delayed : | |||||
|---|---|---|---|---|---|
| Previous Close | $1.99 | 52 Week High | $4.68 | ||
| Open | $1.99 | 52 Week Low | $1.68 | ||
| Day High | $2.07 | P/E | N/A | ||
| Day Low | $1.98 | EPS | $-2.48 | ||
| Volume | 190,210 | ||||
| More ARRY Info: Chart SEC Filings Profile Historical Options | |||||
What is this?Friends, Peers and Foes
| Ticker | # Stories | Ticker | # Stories |
|---|---|---|---|
| RAX | 2 | BIIB | 2 |
| FRPT | 2 | LTXC | 2 |
| MTXX | 2 | CPST | 2 |
| ZQK | 2 | CSCX | 2 |
| IPXL | 1 | MYGN | 1 |
| BCH | 1 | PWRD | 1 |
Entities who have mentioned ARRY
- Robert W Baird | View Related Stories »
- Needham & Co | View Related Stories »
- Citi | View Related Stories »
- S3 | View Related Stories »
- Morgan Stanley | View Related Stories »
- Dividend | View Related Stories »
- After-Hours Movers | View Related Stories »
- Credit Suisse | View Related Stories »
- UBS | View Related Stories »
- Deutsche Bank | View Related Stories »
- Hilliard Lyons | View Related Stories »
- StreetInsider.com Morning Movers | View Related Stories »
- Deerfield Management | View Related Stories »
- Goldman Sachs | View Related Stories »
- Barclays | View Related Stories »
- William Blair | View Related Stories »
- Bakken Formation | View Related Stories »
- KeyBanc | View Related Stories »
- Raymond James | View Related Stories »
- Morgan Joseph | View Related Stories »
- JPMorgan | View Related Stories »
- Notable Analyst Rating Changes | View Related Stories »
- Banc of America | View Related Stories »
- Piper Jaffray | View Related Stories »
- Thomas Weisel Partners Group | View Related Stories »
View All Major News StreetInsider.com Major News for ARRY
- Array BioPharma (ARRY) Reports Q1 Loss of $0.52, Beats by 3c
- Array BioPharma (ARRY) Tops Q4 EPS by 1c on Light Revenues
- Array BioPharma (ARRY) Tops Q4 EPS by 1c
View All ReportsStreetInsider.com Reports on ARRY
- UBS Upgrades Array BioPharma (ARRY) to Buy
- Array BioPharma (ARRY) Reports Q1 Loss of $0.52, Beats by 3c
- Array BioPharma (ARRY) Enters into Equity Distribution Agreement To Sell Up To $25M
- UBS Downgrades Array Biopharma (ARRY) to Neutral
- Unusual 11 Mid-Day Movers 9/4: TONE, JAZZ, LTXC, ESL Higher; ARRY, BPI, ZQK, GIII Lower
View All Press ReleasesCompany Press Releases on ARRY
- Array BioPharma Reports Financial Results for the First Quarter of Fiscal 2010
- Array BioPharma to Report Financial Results for the First Quarter of Fiscal 2010 on November 2, 2009
- Array BioPharma to Present Clinical Results on Diabetes Drug at European Diabetes Meeting
StreetInsider Reports on ARRY by Category
View All BlogsBlogs on ARRY
- Array BioPharma Inc. F1Q10 (Quarter Ended June 30, 2010) Earnings Call Transcript
- Biotech: Q3 Market Update
- Best and Worst Performing Stocks Since Their Last Earnings Report
- Analyst upgrades, downgrades and initiations: AIG, DFS, ERIC, GE, HOG, SYMC ...
- Closing Update for Friday, Sept. 4: Mixed Picture
View All FilingsSEC Filings on ARRY
- Form 4 ARRAY BIOPHARMA INC For: Nov 12 Filed by: KOCH KEVIN
- Form 8-K ARRAY BIOPHARMA INC For: Oct 29
- Form 10-Q ARRAY BIOPHARMA INC For: Sep 30
- Form 8-K ARRAY BIOPHARMA INC For: Nov 02
- Form 4 ARRAY BIOPHARMA INC For: Oct 29 Filed by: ZABRISKIE JOHN L
Comments on recent ARRY articles
Comments on ARRY
No comments are currently available.
on Feb 20, 2008
at 03:42 PM INSM A $3.00 dollar stock trading below a $1.00.
Article: Analyst Call of the Year: Collins Stewart on Encysive (ENCY)